Which phase assesses safety and efficacy after regulatory approval?

• A. Phase I Testing
• B. Phase II Testing
• C. Phase III Testing
• D. Phase IV Testing

Answer: (D)

After a drug gains regulatory approval, ongoing monitoring of its safety and real-world effectiveness occurs in the post-marketing phase. This stage, Phase IV, is dedicated to pharmacovigilance—tracking long-term safety, identifying rare or delayed adverse effects, and understanding how the drug works in a broader, more diverse patient population. It also can provide additional data on how the drug performs in routine practice, potential drug interactions, and optimal use in special groups.

Before approval, safety and efficacy are explored in a sequence of earlier phases: Phase I investigates safety and pharmacokinetics in a small group; Phase II tests preliminary efficacy and helps establish dosing; Phase III confirms effectiveness and safety in a larger population to support regulatory approval. Those phases occur prior to approval, whereas the post-marketing phase happens afterward to ensure ongoing benefit and monitor for any issues that only appear with widespread, real-world use.